Monday, August 26, 2024 11:01:17 AM
You do prove yourself to misread financials, that has been proven, that's all you've proven. And that you argue with what you just called meaningless.
Here's how you can establish your claims, instead of calling it meaningless (that is your new standard means to evade providing reason and explanation):
1.) If no shares, why does XTI say it issued shares to Xeriant?
2.) Why did XTI classify its $5.4M obligation to Xeriant as an equity liability obligation, not a cash liability?
3,) Why was equity shares issued to Xeriant, and not cash, in particular if you're correct that XTI was only to pay cash?
4,) Why was the annual adjustment to the valuation of XTI's equity liability obligation to Xeriant adjusted by the exact same amount that you claim is actually the full entire cash liability obligation, that you claim as obligation was cash only, not equity shares?
5.) Why was no cash paid by XTI to Xeriant for XTI to settle its liability obligation after the JV ran its full term and prior to XTI's merger?
6.) Why was equity XTI shares paid by XTI to Xeriant for XTI to settle its liability obligation after the JV ran its full term and prior to XTI's merger?
They weren't. They aren't. They didn't. (except #6, which did)
But that would mean you're wrong. And multiple times wrong too (which you are).
But maybe you can explain an answer to each above that is correct, and that makes any sense, and that is not another of your lies, or is not you just evading explanation with CRICKETS.
You can't. You won't. Because you're a fraud.
FACT!
.
© 2024, by StockItOut
Recent XERI News
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/08/2024 01:19:43 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/30/2024 05:23:29 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 05:20:07 PM
- Form SEC STAFF ACTION - SEC Staff Action: ORDER • Edgar (US Regulatory) • 03/08/2024 06:00:01 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 05:43:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 09:35:19 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 10:05:01 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/16/2023 11:27:32 AM
ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM
CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products • CBDL • Oct 10, 2024 8:00 AM
Foremost Lithium Announces Option Agreement with Denison on 10 Uranium Projects Spanning over 330,000 Acres in the Athabasca Basin, Saskatchewan • FAT • Oct 10, 2024 5:51 AM
Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • ELEM • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM